This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Obesity » Type 2

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Alarming Message From the 19th World Diabetes Congress

Posted: Thursday, December 14, 2006

That diabetes is fast becoming the epidemic of the 21st century which, now affects a shocking 246 million people worldwide, and is expected to affect over 380 million by 2025 if no action is taken.

Diet Drug Acomplia (Rimonabant) Lowers Blood Sugars and Reduces Weight

Posted: Thursday, December 14, 2006

New study results show patients with an HbA1c level of at least 8.5 when they started taking Acomplia saw their their blood sugar level decrease 1.9 points compared to 0.7 points in patients on a placebo.

Januvia Combo Soon to Be Available - JANUMET

Posted: Thursday, December 07, 2006

Within weeks of Januvia being approved, Merck & Co. is ready to come out with a combination product of Januvia and metformin.

Sitagliptin Role As Monotherapy, Adjunct

Posted: Thursday, November 30, 2006

The newly licensed glucose-lowering agent sitagliptin phosphate (Januvia) appears safe and somewhat effective. It could become a replacement for sulfonylurea, due to its ability to control blood sugars without weight gain and hypoglycemia.

One in Six Americans Have Pre-Diabetes and Most Don't Know It

Posted: Wednesday, November 22, 2006

Fifty-four million Americans, that's one in six of us, have pre-diabetes and most don't even realize it. Mark Schutta, MD, medical director of the Penn Rodebaugh Diabetes Center, is urging at-risk patients to be proactive and ask your doctor to give you a simple blood test for pre-diabetes, to arm yourself with information before the damage is done. It means you have blood glucose levels that are higher than normal and you could one day reach a high enough level that you would be diagnosed with having diabetes.

Rimonabant (Accomplia) to Treat Obesity and Improve Glycemic Control Approved in Mexico

Posted: Wednesday, November 22, 2006

Accomplia is now approved in Europe and Mexico, US next?

Lifestyle Change Cuts Weight, CVD Risk in Diabetes

Posted: Thursday, November 16, 2006

Control group had lost a mean of 8.3% of their body weight. One-year data obtained from a large, federally funded trial have shown that intensive lifestyle intervention can produce significant weight loss and reduce cardiovascular risk factors in patients with type 2 diabetes.

Children's Belly Fat Increases More Than 65 Percent Since 1990's

Posted: Thursday, November 16, 2006

Abdominal obesity increased more than 65 percent among boys and almost 70 percent among girls between 1988 and 2004. The finding of growing girth is significant because abdominal obesity has emerged as a better predictor of cardiovascular disease and type 2 diabetes risk than the more commonly used Body Mass Index, a weight to height ratio that can sometimes be misleading.

Three Years Later, Participants in the Diabetes Prevention Study Still Benefiting

Posted: Thursday, November 16, 2006

The effects of lifestyle intervention on diabetes risk do not disappear after active counseling has stopped, a new follow-up of the Finnish Diabetes Prevention Study shows.

Acomplia ™(Rimonabant) Receives 1st Marketing Authorization in North America

Posted: Thursday, November 16, 2006

Acomplia™ (rimonabant) approved in Mexico to treat obese/overweight patients with associated type 2 diabetes or dyslipidemia or to help them improve glycemic control on background of conventional antidiabetic treatment.